Thermo Fisher Scientific (TMO) Tops Q1 EPS by 13c; Boosts FY14 Outlook

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $1.53, $0.13 better than the analyst estimate of $1.40. Revenue for the quarter came in at $3.9 billion versus the consensus estimate of $3.74 billion.

Thermo Fisher Scientific sees FY2014 EPS of $6.80 - $6.95, versus prior guidance of $6.70 - $6.95 and the consensus of $6.85. Thermo Fisher Scientific sees FY2014 revenue of $16.84 - $17.00 billion, versus prior guidance of $16.63 - $16.83 billion and the consensus of $16.82 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Omega Flex (OFLX) Tops Q2 EPS by 27c
• Sandisk targets mid-to-high teens revenue growth through FY2030